Slide 1: Biocon Group Fact Sheet March 2015
BIOCON GROUP FACT SHEET March - 2015
Slide 2: Biocon Limited (Consolidated) Balance Sheet
BIOCON LIMITED (CONSOLIDATED) BALANCE SHEET (Rs. Crores) March 31, 2015 March 31, 2014 EQUITY AND LIABILITIES Shareholder's Funds (a) Share capital 100 100 (b)Reserves and surplus 3,171 2,927 3,271 3,027 Minority interest 172 82 Non-current liabilities (a) Long-term borrowings 770 606 (b)Deferred ta
Slide 3: Biocon Limited (Consolidated) Profit & Loss Statement FY15
0 - BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crores) Particulars FY 15 FY 14 Variance INCOME Biopharmaceuticals 2,236 2,138 5% Biopharma * 1,806 1,747 3% Branded formulations - India 430 391 10% Contract research 823 715 15% Total Sales 3,059 2,853 7% Other income 84 80 4% Total Re
Slide 4: Biocon Limited (Consolidated) Profit & Loss Statement Q4 FY15 vs Q4 FY14
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crores) Q4 Q4 Particulars FY 15 FY 14 Variance INCOME Biopharmaceuticals 592 535 11% Biopharma * 494 442 12% Branded formulations - India 98 93 6% Contract research 238 188 27% Total Sales 830 723 15% Other income 24 23 8% TOTAL REVENUE 854
Slide 5: Biocon Limited (Consolidated) Profit & Loss Statement Q4 vs Q3 FY15
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crores) Q4 Q3 Particulars FY 15 FY 15 Variance INCOME Biopharmaceuticals 592 541 9% Biopharma * 494 436 13% Branded formulations - India 98 105 -6% Contract research 238 220 9% Total Sales 830 761 9% Other income 24 18 34% 854 779 10% EXPEND